| Literature DB >> 10227787 |
H Onodera, Y Abe, M Yoshida, N Yamawaki, Y Yamashita, H Matsuo, K Ichinose, I Otsuru, N Shibuya.
Abstract
To control antigen (Ag)-specific immune cells is important in the treatment of autoimmune diseases. In particular, a direct solution may be obtained by controlling the CD4+ cell function that controls the immune response of autoimmune T cells. Thus, a technique to selectively remove CD4+ cells has been developed, based on the consideration that the immune system may possibly be modified by selectively removing the CD4+ cells by means of extracorporeal circulation. The currently developed device to selectively remove CD4+ cells uses a material made of nonwoven fabric with monoclonal antibodies immobilized on the surface. With this device, removal of only CD4+ cells from human mononuclear cells suspension can be accomplished. Moreover, CD4+ cells can be specifically removed from peripheral whole blood by direct perfusion. This review outlines a series of procedures for selective cell removal and the results of our research.Entities:
Mesh:
Year: 1998 PMID: 10227787 DOI: 10.1111/j.1744-9987.1998.tb00071.x
Source DB: PubMed Journal: Ther Apher ISSN: 1091-6660